Key answer
Kelly Clarkson has stated on public records and in interviews that she used semaglutide for weight management. This medication, a GLP-1 receptor agonist also sold under brand names such as Ozempic and Wegovy, is typically prescribed for type 2 diabetes and obesity and is known to reduce appetite and promote weight loss when combined with diet and exercise. The following sections explain what semaglutide is, how it works, common uses, considerations, and how Clarkson has discussed the topic.
What is semaglutide
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a hormone involved in blood sugar control and appetite regulation. It is approved by the FDA for the management of type 2 diabetes and, at higher doses, for chronic weight management in adults with obesity or overweight with at least one weight-related condition. Semaglutide is not a stimulant and does not act directly on the brain's reward centers; instead, it slows gastric emptying and acts on brain regions involved in hunger to help people eat less.
How semaglutide works in the body
Semaglutide binds to GLP-1 receptors in the pancreas to promote insulin release in response to meals, lowers glucagon release, and slows gastric emptying. These effects help reduce post-meal blood sugar spikes and increase feelings of fullness after smaller meals. In weight management, these mechanisms can lead to reduced calorie intake and, over time, meaningful weight loss when paired with lifestyle changes.
Approved uses and dosing
- Type 2 diabetes: Improves blood sugar control in adults and some children, often alongside diet and exercise.
- Weight management: Approved for chronic weight management in adults with obesity (BMI 30 or greater) or overweight (BMI 27 or greater) with at least one weight-related condition, under the brand name Wegovy.
- Dosing is titrated gradually to reduce gastrointestinal side effects, with maintenance dosing determined by a healthcare professional.
Common brand names and forms
Semaglutide is available as a once-weekly subcutaneous injection under the brand names Ozempic (primarily for diabetes) and Wegovy (for weight management), and as an oral tablet known as Rybelsus. The injectable forms are pre-filled pens designed for at-home use, while the oral version offers an alternative for those who prefer not to use injections.
Evidence and effectiveness for weight loss
Clinical trials have shown that semaglutide can lead to significant weight loss compared to placebo when combined with a reduced-calorie diet and increased physical activity. In one large trial, adults taking the highest approved dose for weight management lost an average of about 15% of their body weight over 68 weeks. Individual results vary based on baseline weight, adherence to lifestyle changes, and tolerance of side effects.
Typical results observed in studies
| Metric | Verified Detail | Source Type |
|---|---|---|
| Average weight loss | Up to ~15% of body weight in trials over 68 weeks at the highest dose | Clinical trial data |
| Dose used for weight management | Wegovy 2.4 mg once weekly | Regulatory labeling |
| Onset of meaningful change | Visible changes often seen by week 16; continued loss through 68 weeks | Study reports |
| Common side effects | Nausea, vomiting, diarrhea, constipation, stomach pain | Labeling and clinical reports |
Medical considerations and safety
Semaglutide is not suitable for everyone and can cause side effects, especially gastrointestinal symptoms such as nausea, vomiting, and diarrhea, which often improve over time as the dose is increased slowly. It is generally not recommended for individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. People considering semaglutide should undergo a medical evaluation, discuss their complete medical history, and be monitored by a healthcare professional.
How Kelly Clarkson has discussed it
In interviews and on her talk show, Kelly Clarkson has addressed her use of medication for weight management in a candid manner. She emphasized that she works closely with medical professionals, follows a structured plan, and combines treatment with lifestyle changes. While she has mentioned the positive impact on her health and confidence, she also acknowledges the importance of sustainable habits and mental wellness.
Practical context and realistic expectations
Weight loss medications like semaglutide are tools that work best when part of a comprehensive plan that includes calorie-controlled nutrition, regular movement, sleep, and behavioral support. They are not a shortcut: meaningful results usually require months of consistent effort and medical oversight. Anyone considering medication should set realistic goals, track progress with measurable outcomes, and maintain regular communication with their care team.
When to consult a healthcare professional
Because semaglutide can interact with other medications and is not appropriate for all medical histories, a qualified provider should assess whether it is a good fit. If you are considering weight loss medication, discuss your specific risk factors, current medications, and goals so your provider can tailor a plan that is safe and effective for you.